BioArctic Financials

BIOA-B Stock

SEK 189.60 4.20 2.27%

We suggest to use BioArctic AB fundamental analysis to see if markets are presently undervaluing or overvaluing the company. Put another way, you can use it to find out if BioArctic AB is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to break down and interpolate data for thirty available fundamental indicators for BioArctic AB, which can be compared to its peers. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of BioArctic to be traded at kr227.52 in 90 days.

Understanding current and past BioArctic Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioArctic's financial statements are interrelated, with each one affecting the others. For example, an increase in BioArctic's assets may result in an increase in income on the income statement.

Please note, the presentation of BioArctic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioArctic's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BioArctic's management manipulating its earnings.

BioArctic Stock Summary

BioArctic competes with Bavarian Nordic, BioPorto, Zaptec AS, and CBrain AS. BioArctic AB , a research intensive biopharmaceutical company, develops disease modifying treatments and diagnostics for neurodegenerative diseases in Sweden. BioArctic AB was founded in 1992 and is headquartered in Stockholm, Sweden. BioArctic is traded on Stockholm Stock Exchange in Sweden.

Instrument	Sweden Stock View All
Exchange	Stockholm Exchange
ISIN	SE0010323311
Business Address	Warfvinges vag 35,
Sector	Healthcare
Industry	Biotechnology
Benchmark	Dow Jones Industrial
Website	www.bioarctic.se
Phone	46 86 95 69 30
Currency	SEK - Swedish Kronor

You should never invest in BioArctic without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of BioArctic Stock, because this is throwing your money away. Analyzing the key information contained in BioArctic's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

BioArctic Key Financial Ratios

BioArctic's financial ratios allow both analysts and investors to convert raw data from BioArctic's financial statements into concise, actionable information that can be used to evaluate the performance of BioArctic over time and compare it to other companies across industries.

	Return On Equity	-0.0142
	Return On Asset	-0.0055
	Target Price	393.2
	Number Of Employees	61
	Beta	0.61

More Fundamentals

BioArctic Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BioArctic's current stock value. Our valuation model uses many indicators to compare BioArctic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioArctic competition to find correlations between indicators driving BioArctic's intrinsic value. More Info.

BioArctic AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioArctic by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioArctic's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

BioArctic AB Systematic Risk

BioArctic's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioArctic volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.

The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on BioArctic AB correlated with the market. If Beta is less than 0 BioArctic generally moves in the opposite direction as compared to the market. If BioArctic Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioArctic AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioArctic is generally in the same direction as the market. If Beta > 1 BioArctic moves generally in the same direction as, but more than the movement of the benchmark.

BioArctic November 23, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of BioArctic help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioArctic AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioArctic AB based on widely used predictive technical indicators. In general, we focus on analyzing BioArctic Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioArctic's daily price indicators and compare them against related drivers.

	Downside Deviation	3.23
	Information Ratio	0.0366
	Maximum Drawdown	39.02
	Value At Risk	(4.55)
	Potential Upside	6.39

Complementary Tools for BioArctic Stock analysis

When running BioArctic's price analysis, check to measure BioArctic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioArctic is operating at the current time. Most of BioArctic's value examination focuses on studying past and present price action to predict the probability of BioArctic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioArctic's price. Additionally, you may evaluate how the addition of BioArctic to your portfolios can decrease your overall portfolio volatility.

	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC